Pure Global

Innova β2-glycoprotein I immunoglobulin G enzyme linked immunoassay test system (unsterilized) - Taiwan Registration 957fd686cf3a38e2574741cf413f1f26

Access comprehensive regulatory information for Innova β2-glycoprotein I immunoglobulin G enzyme linked immunoassay test system (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 957fd686cf3a38e2574741cf413f1f26 and manufactured by INOVA DIANOSTICS, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
957fd686cf3a38e2574741cf413f1f26
Registration Details
Taiwan FDA Registration: 957fd686cf3a38e2574741cf413f1f26
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Innova β2-glycoprotein I immunoglobulin G enzyme linked immunoassay test system (unsterilized)
TW: 因諾瓦β2-醣蛋白I免疫球蛋白G酵素連結免疫分析法檢驗系統(未滅菌)
Risk Class 1

Registration Details

957fd686cf3a38e2574741cf413f1f26

DHA04400218301

Company Information

United States

Product Details

Semi-quantitative detection of β2 GPI IgG antibodies in human serum samples by immunoenzyme method (ELISA).

C Immunology and microbiology

C.5430 β-2-醣蛋白I免疫試驗系統

import

Dates and Status

Dec 01, 2005

Dec 01, 2025